Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;26(6):1242-51.
doi: 10.1002/jbmr.339.

Skeletal recovery after weaning does not require PTHrP

Affiliations

Skeletal recovery after weaning does not require PTHrP

Beth J Kirby et al. J Bone Miner Res. 2011 Jun.

Abstract

Mice lose 20% to 25% of trabecular bone mineral content (BMC) during lactation and restore it after weaning through unknown mechanisms. We found that tibial Pthrp mRNA expression was upregulated fivefold by 7 days after weaning versus end of lactation in wild-type (WT) mice. To determine whether parathyroid hormone-related protein (PTHrP) stimulates bone formation after weaning, we studied a conditional knockout in which PTHrP is deleted from preosteoblasts and osteoblasts by collagen I promoter-driven Cre (Cre(ColI) ). These mice are osteopenic as adults but have normal serum calcium, calcitriol, and parathyroid hormone (PTH). Pairs of Pthrp(flox/flox) ;Cre(ColI) (null) and WT;Cre(ColI) (WT) females were mated and studied through pregnancy, lactation, and 3 weeks of postweaning recovery. By end of lactation, both genotypes lost lumbar spine BMC: WT declined by 20.6% ± 3.3%, and null decreased by 22.5% ± 3.5% (p < .0001 versus baseline; p = NS between genotypes). During postweaning recovery, both restored BMC to baseline: WT to -3.6% ± 3.7% and null to 0.3% ± 3.7% (p = NS versus baseline or between genotypes). Similar loss and full recovery of BMC were seen at the whole body and hind limb. Histomorphometry confirmed that nulls had lower bone mass at baseline and that this was equal to the value achieved after weaning. Osteocalcin, propeptide of type 1 collagen (P1NP), and deoxypyridinoline increased equally during recovery in WT and null mice; PTH decreased and calcitriol increased equally; serum calcium was unchanged. Urine calcium increased during recovery but remained no different between genotypes. Although osteoblast-derived PTHrP is required to maintain adult bone mass and Pthrp mRNA upregulates in bone after weaning, it is not required for recovery of bone mass after lactation. The factors that stimulate postweaning bone formation remain unknown.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Pthrp mRNA expression is upregulated in bone during postweaning recovery. Weaning was forced on day 12 of lactation, and skeletal mRNA was analyzed by real-time quantitative RT-PCR. PTHrP expression increased more than fivefold in bone through the first 7 days after weaning. Values were normalized to GAPDH and then expressed relative to the value on day 12 of lactation.
Fig. 2
Fig. 2
obPthrp null and WT mice experience identical changes in BMC during pregnancy and lactation and after weaning. Relative changes in whole-body (A), spine (B), and hind limb (C) BMC versus baseline are depicted on day 18.5 of pregnancy, day 21 of lactation, and day 21 of postweaning recovery. The number of observations is indicated in parentheses.
Fig. 3
Fig. 3
Bone turnover is increased after weaning. The bone markers osteocalcin (A), deoxypyridinoline (B), and P1NP (C) increased equally in WT and obPthrp null mice during postweaning recovery compared with the prepregnancy baseline. Depicted here are baseline, day 18.5 of pregnancy, day 21 of lactation, and day 7 of postweaning recovery. The most marked increase in bone resorption occurs during the first 10 days of lactation, but the time point assayed here was day 21 of lactation, when the pups were weaned. The number of observations is indicated in parentheses.
Fig. 4
Fig. 4
Flux in PTH and calcitriol during reproductive cycles. (A) PTH normally becomes suppressed during pregnancy and lactation but rises to baseline during postweaning recovery. This pattern was noted in WT and obPthrp null mice, although the changes were not statistically significant. (B) Calcitriol tripled during pregnancy, as expected, and then declined during recovery but remained double the baseline value. No significant differences were seen between WT and obPthrp null mice. Time points depicted are baseline, day 18.5 of pregnancy, day 21 of lactation, and day 7 of postweaning recovery. The number of observations is indicated in parentheses.
Fig. 5
Fig. 5
Flux in urinary calcium and phosphorus during reproductive cycles. (A) Urinary calcium normally increases during pregnancy and decreases during lactation; the fall during lactation was statistically significant. (B) Urinary phosphorus decreased nonsignificantly during pregnancy but increased significantly during lactation as a consequence of enhanced bone resorption and possibly PTHrP-stimulated phosphaturia. In all panels, there were no significant differences between WT and obPthrp null mice. Time points depicted are baseline, day 18.5 of pregnancy, day 21 of lactation, and day 7 of postweaning recovery. The number of observations is indicated in parentheses.

Similar articles

Cited by

References

    1. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium and lactation. Endocr Rev. 1997;18:832–872. - PubMed
    1. Kovacs CS, El-Hajj Fuleihan G. Calcium and bone disorders during pregnancy and lactation. Endocrinol Metab Clin North Am. 2006;35:21–51. - PubMed
    1. Wysolmerski JJ. Conversations between breast and bone: physiological bone loss during lactation as evolutionary template for osteolysis in breast cancer and pathological bone loss after menopause. BoneKEy. 2007;4:209–225.
    1. Kovacs CS. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab. 2001;86:2344–2348. - PubMed
    1. Kovacs CS. Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia. 2005;10:105–118. - PubMed

Publication types

MeSH terms